Sellar and Suprasellar Masses

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Sellar and Suprasellar Masses trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedNot Applicable

NCT04369703

Copeptin as a Biomarker for Central Diabetes Insipidus Development Following Pituitary Surgery

1. Access the optimal cut point value of copeptin which predicts development of central diabetes insipidus postoperatively with highest accuracy. 2. Access the…

United States199 participantsStarted 2020-01-28